A phase 1 expansion cohort of the fibroblast growth factor receptor (FGFR) inhibitor AZD4547 in patients (pts) with advanced gastric (GC) and gastroesophageal (GOJ) cancer.
Hendrik-Tobias Arkenau
No relevant relationships to disclose
Matilde Saggese
No relevant relationships to disclose
Antoine Hollebecque
No relevant relationships to disclose
Alastair Mathewson
Employment or Leadership Position - AstraZeneca
Charlotte Rose Lemech
No relevant relationships to disclose
Donal Landers
Employment or Leadership Position - AstraZeneca
Paul Frewer
Employment or Leadership Position - AstraZeneca
Elaine Kilgour
Employment or Leadership Position - AstraZeneca
Nigel Brooks
Employment or Leadership Position - AstraZeneca